Yong Xia Selected Research

Mitoxantrone (Novantrone)

10/2021	Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells.
11/2020	Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Xia Research Topics

Disease

90	Neoplasms (Cancer) 05/2024 - 05/2007
41	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2010
33	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 05/2007
20	Inflammation (Inflammations) 01/2023 - 09/2003
14	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2014
12	Infections 02/2024 - 01/2012
11	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024 - 07/2018
11	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2014
9	Cholangiocarcinoma 05/2024 - 03/2013
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2013
8	Fibrosis (Cirrhosis) 01/2022 - 07/2013
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 11/2007
7	Sepsis (Septicemia) 02/2023 - 05/2006
6	Melanoma (Melanoma, Malignant) 03/2024 - 02/2016
6	Myocardial Infarction 03/2024 - 11/2017
6	Atherosclerosis 03/2024 - 11/2007
6	Carcinogenesis 01/2023 - 04/2016
6	Thrombosis (Thrombus) 01/2021 - 12/2016
5	Triple Negative Breast Neoplasms 12/2023 - 01/2018
5	Carcinoma (Carcinomatosis) 10/2023 - 08/2013
4	Reperfusion Injury 01/2022 - 06/2011
4	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2017
4	Tuberculosis (Tuberculoses) 01/2020 - 03/2013
3	Lymphoma (Lymphomas) 12/2023 - 05/2019
3	Margins of Excision 01/2023 - 05/2007
3	Disease Progression 01/2022 - 05/2019
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2021 - 07/2013
3	Hypoxia (Hypoxemia) 01/2021 - 07/2019
3	Heart Failure 01/2020 - 11/2009
3	Lung Neoplasms (Lung Cancer) 01/2020 - 11/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 09/2007
3	Stroke (Strokes) 03/2019 - 01/2018
2	Thalassemia 03/2024 - 08/2015
2	Liver Neoplasms (Liver Cancer) 12/2023 - 08/2023
2	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2022
2	COVID-19 08/2023 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2011
17	Biomarkers (Surrogate Marker)IBA 09/2023 - 08/2015
10	Antipsychotic Agents (Antipsychotics)IBA 04/2024 - 01/2018
7	MicroRNAs (MicroRNA)IBA 09/2022 - 01/2014
6	Messenger RNA (mRNA)IBA 10/2023 - 01/2011
6	CytokinesIBA 01/2023 - 03/2014
6	Interleukin-8 (Interleukin 8)IBA 01/2022 - 12/2013
5	Therapeutic UsesIBA 02/2024 - 10/2010
5	Fetal Proteins (Fetoprotein)IBA 01/2023 - 04/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2016
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2008
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 09/2003
5	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020 - 10/2014
5	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2015
4	CateninsIBA 05/2024 - 01/2021
4	EnzymesIBA 02/2024 - 02/2016
4	nifuroxazide (Akabar)IBA 06/2022 - 02/2016
4	Circular RNAIBA 01/2022 - 01/2019
4	Carcinoembryonic AntigenIBA 01/2022 - 03/2013
4	Retinaldehyde (Retinal)IBA 01/2022 - 01/2011
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021 - 09/2007
4	VaccinesIBA 01/2020 - 01/2012
4	CarcinogensIBA 10/2019 - 01/2015
4	Urokinase Plasminogen Activator ReceptorsIBA 07/2018 - 10/2014
3	AlkaloidsIBA 02/2024 - 01/2015
3	Tumor Biomarkers (Tumor Markers)IBA 12/2023 - 12/2019
3	Alkaline PhosphataseIBA 09/2023 - 07/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2023 - 03/2017
3	BilirubinIBA 01/2023 - 11/2017
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
3	FlavonoidsIBA 06/2022 - 04/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2020
3	AntigensIBA 01/2022 - 07/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
3	InflammasomesIBA 01/2022 - 01/2019
3	CarbohydratesIBA 01/2022 - 07/2017
3	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2021 - 01/2018
3	PhytochemicalsIBA 01/2021 - 04/2015
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2011
3	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 02/2016
3	Long Noncoding RNAIBA 10/2020 - 05/2019
3	LipidsIBA 04/2020 - 11/2007
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 08/2010
3	RON proteinIBA 01/2020 - 04/2015
3	Capsules (Microcapsules)IBA 04/2016 - 05/2007
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2015 - 09/2013
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2015 - 05/2007
2	Oxidoreductases (Dehydrogenase)IBA 02/2024 - 12/2020
2	SteroidsIBA 02/2024 - 01/2021
2	Prealbumin (Transthyretin)IBA 01/2024 - 01/2023
2	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2019
2	talaroconvolutin AIBA 10/2023 - 11/2020
2	LipopolysaccharidesIBA 02/2023 - 06/2011
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2023 - 09/2003

Therapy/Procedure

38	Therapeutics 04/2024 - 12/2010
28	Hepatectomy 12/2023 - 10/2012
9	Drug Therapy (Chemotherapy) 12/2023 - 08/2013
5	Radiotherapy 01/2023 - 01/2016
5	Stents 01/2021 - 11/2017
4	Immunotherapy 01/2023 - 01/2021
4	Oral Administration 01/2020 - 02/2012
3	Aftercare (After-Treatment) 04/2024 - 01/2015
2	Ligation 03/2024 - 02/2023